Lineage Cell Therapeutics, Inc.
LCTXNext catalyst
Data Readout — COR1
Get an email about LCTX's next catalysts
Track Lineage Cell Therapeutics (LCTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 1 past
Data Readout — COR1
Lineage announced cash runway extending into Q3 2028 and guided for COR1 in vivo data by year-end 2026.
SourceMarket Overview
Stock performance and key metrics
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AST-OPC1 | Phase 2 | Cervical Spinal Cord Injury | - | - |
Frequently asked questions
What is in Lineage Cell Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Lineage Cell Therapeutics, Inc.'s (LCTX) pipeline across Phase 2. Its lead program is AST-OPC1 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Lineage Cell Therapeutics, Inc.'s next FDA catalyst?→
Lineage Cell Therapeutics, Inc.'s (LCTX) next tracked catalyst is a data readout expected Dec 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LCTX biotech catalysts?→
Add LCTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lineage Cell Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.